Page last updated: 2024-12-05

9,10-phenanthrenequinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9,10-phenanthrenequinone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6763
CHEMBL ID51931
CHEBI ID37454
SCHEMBL ID43050
MeSH IDM0046918

Synonyms (77)

Synonym
phenanthrene-9,10-quinone
phenanthrene,10-dihydro-9,10-dioxo-
9,10-phenanthraquinone
nsc7389
nsc-7389
9,10-phenanthrenequinone
wln: l b666 hvvj
smr000150826
MLS000571180 ,
phenanthrene chinone
1,2-dione-based compound, 14
cid_6763
bdbm22857
phenanthrene-9,10 dione
chembl51931 ,
9,10-dihydrophenanthrene-9,10-dione
CHEBI:37454 ,
nsc 10446
ccris 7615
brn 0608838
9-10 phenanthrene quinone
ai3-23739
einecs 201-515-5
phenanthrene, 9,10-dihydro-9,10-dioxo-
hsdb 4489
nsc10446
nsc-10446
phenanthrene-9,10-dione
9,10-phenanthroquinone
C03243
phenanthraquinone
84-11-7
phenanthrenequinone ,
9,10-phenanthrenedione
9,10-phenanthrenequinone, >=99%
9,10-phenanthrenequinone, 95%
MLS000881132 ,
KUC103886N
ksc-1-127
P0080
P1136
AKOS000120609
A840718
NCGC00246089-01
sr-01000512656
SR-01000512656-4
STK793149
HMS2231F24
42l7bz8h74 ,
unii-42l7bz8h74
4-07-00-02565 (beilstein handbook reference)
FT-0621602
REGID_FOR_CID_6763
phenanthrenequinone [mi]
CX1139
AF-936/31262009
SCHEMBL43050
BP-13416
DTXSID3058901
phenanthroquinone
W-104124
Q-201551
OPERA_ID_1159
mfcd00001163
SR-01000512656-1
9,10-phenanthrenequinone, vetec(tm) reagent grade, 94%
phenanthrenchinon
Z56943754
CS-W015223
Q25103737
AS-14257
3-pyrrolidin-2-yl-propionicacid
AMY37107
9,10-phenanthrquinone
SB67051
9,10-phenanthrenedione phenanthrenequinone
EN300-17486

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Other CBR substrates such as menadione, phenanthrenequinone, and doxorubicin were equally toxic to both the CBR expresser cells and the control cells under the conditions tested."( Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells.
Akman, S; Doroshow, J; Forrest, GL; Gonzalez, B; Kaplan, WD; Rivera, H, 1995
)
0.29
" These results indicate potential toxic interactions between metals and modified PAHs."( Assessment of the toxicity of mixtures of nickel or cadmium with 9,10-phenanthrenequinone to Daphnia magna: impact of a reactive oxygen-mediated mechanism with different redox-active metals.
Dixon, DG; Greenberg, BM; Lampi, MA; Xie, F, 2007
)
0.58
"Diesel exhaust particles (DEPs) are major components of ambient particulate matter and are associated with various adverse health effects."( ROS-independent cytotoxicity of 9,10-phenanthrenequinone inhibits cell cycle progression and spindle assembly during meiotic maturation in mouse oocytes.
Kim, JS; Kim, S; Leem, J; Oh, JS, 2022
)
1

Dosage Studied

ExcerptRelevanceReference
"A simple and highly sensitive method is proposed for the fluorimetric determination of streptomycin in dosage forms and in biological fluids."( Spectrofluorimetric determination of streptomycin in dosage forms and in spiked plasma using 9,10-phenanthraquinone.
Belal, F; El Kerdawy, MM; El Wasseef, DR; El-Ashry, SM, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenanthrenesAny benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (89)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency2.81840.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency4.61740.140911.194039.8107AID2451; AID2785; AID2787
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency3.54810.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency24.90530.125919.1169125.8920AID2549; AID504841
Chain A, CruzipainTrypanosoma cruziPotency35.71680.002014.677939.8107AID1476; AID1478
glp-1 receptor, partialHomo sapiens (human)Potency3.54810.01846.806014.1254AID624417
thioredoxin reductaseRattus norvegicus (Norway rat)Potency6.58120.100020.879379.4328AID588453; AID588456
ATAD5 protein, partialHomo sapiens (human)Potency5.28600.004110.890331.5287AID504466; AID504467
USP1 protein, partialHomo sapiens (human)Potency1.00000.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency0.54900.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency2.21060.180013.557439.8107AID1460; AID1468
thioredoxin glutathione reductaseSchistosoma mansoniPotency1.77830.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency1.12200.00527.809829.0929AID588855
regulator of G-protein signaling 4Homo sapiens (human)Potency19.95260.531815.435837.6858AID504845
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency0.89130.28189.721235.4813AID2326
67.9K proteinVaccinia virusPotency3.64260.00018.4406100.0000AID720579; AID720580
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency22.38720.707936.904389.1251AID504333
IDH1Homo sapiens (human)Potency0.92000.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency5.01190.035520.977089.1251AID504332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency19.95260.540617.639296.1227AID2528
galactokinaseHomo sapiens (human)Potency2.52210.943115.289453.0367AID1868; AID2015
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency3.54810.01262.451825.0177AID485313
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency5.06190.354828.065989.1251AID504847; AID602199; AID602200; AID602201; AID602202
fructose-bisphosphate aldolase AOryctolagus cuniculus (rabbit)Potency0.89130.891316.576239.8107AID2794
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency3.98110.010039.53711,122.0200AID1469
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency18.35640.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency11.22023.548119.542744.6684AID743266
glyceraldehyde-3-phosphate dehydrogenase isoform 1Homo sapiens (human)Potency1.12201.122011.187739.8107AID2795
huntingtin isoform 2Homo sapiens (human)Potency2.81840.000618.41981,122.0200AID1688
DNA polymerase betaHomo sapiens (human)Potency15.84890.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency3.54810.039816.784239.8107AID1454
ras-related protein Rab-9AHomo sapiens (human)Potency2.81840.00022.621531.4954AID485297
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency28.18380.010323.856763.0957AID2662
DNA polymerase eta isoform 1Homo sapiens (human)Potency2.51190.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency0.70790.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency1.41250.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency1.41250.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency1.41250.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency2.57880.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency7.95230.004611.374133.4983AID624296; AID624297
VprHuman immunodeficiency virus 1Potency4.46681.584919.626463.0957AID651644
survival motor neuron protein isoform dHomo sapiens (human)Potency17.78280.125912.234435.4813AID1458
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency25.11890.00419.962528.1838AID2675
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinaseArabidopsis thaliana (thale cress)Potency2.658147.269047.269047.2690AID2017
lamin isoform A-delta10Homo sapiens (human)Potency3.16230.891312.067628.1838AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency3.16230.015812.3113615.5000AID1461
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency8.91256.309660.2008112.2020AID720709
Adenosine receptor A1Rattus norvegicus (Norway rat)Potency3.16230.06314.137115.8489AID1868
Guanine nucleotide-binding protein GHomo sapiens (human)Potency17.78281.995325.532750.1187AID624288
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency17.78281.000010.475628.1838AID1457
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency50.11873.981146.7448112.2020AID720708
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency6.50890.07578.474229.0628AID602233; AID686980
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sphingosine-1-phosphate receptor 4Homo sapiens (human)IC50 (µMol)2.02900.08900.70152.0290AID1692
PTK2B protein tyrosine kinase 2 betaHomo sapiens (human)IC50 (µMol)69.50001.53704.08056.9220AID1641
Valosin-containing proteinHomo sapiens (human)IC50 (µMol)50.00000.11006.018728.0000AID1534; AID1544
Phospholipase C, gamma 1Homo sapiens (human)IC50 (µMol)6.37201.21203.16626.3720AID743329
Apoptotic peptidase activating factor 1Homo sapiens (human)IC50 (µMol)50.27450.037518.623253.2000AID588524; AID588538
photoreceptor-specific nuclear receptorHomo sapiens (human)IC50 (µMol)39.84100.03742.93408.9620AID2758
phospholipase A2 precursorHomo sapiens (human)IC50 (µMol)42.80001.02009.002515.2000AID588400
perilipin-5Homo sapiens (human)IC50 (µMol)6.44300.98503.45659.4680AID504319
nuclear receptor corepressor 2 isoform 2Homo sapiens (human)IC50 (µMol)1.83901.02504.36119.9550AID2759
perilipin-1Homo sapiens (human)IC50 (µMol)12.28400.92503.30339.6190AID504317
caspase-9 isoform alpha precursorHomo sapiens (human)IC50 (µMol)0.90300.025616.507052.8000AID588574
sphingosine 1-phosphate receptor 1Homo sapiens (human)IC50 (µMol)5.02001.41804.64948.7060AID1821
caspase-3 isoform a preproproteinHomo sapiens (human)IC50 (µMol)0.90300.025620.323574.3000AID588574
protein-arginine deiminase type-4Homo sapiens (human)IC50 (µMol)16.00002.50002.50002.5000AID492970
cysteine protease ATG4B isoform aHomo sapiens (human)IC50 (µMol)1.25001.250010.663219.1000AID504756
peroxisome proliferator-activated receptor gamma isoform 2Homo sapiens (human)IC50 (µMol)1.83901.02504.36119.9550AID2759
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)IC50 (µMol)9.36350.92503.58289.6190AID504317; AID504319
tyrosyl-DNA phosphodiesterase 2Homo sapiens (human)IC50 (µMol)1.90700.16113.96438.0090AID743297
Cocaine esteraseHomo sapiens (human)Ki0.05200.00630.98358.0000AID731514
Telomerase reverse transcriptaseHomo sapiens (human)IC50 (µMol)2.75000.00062.69489.4000AID694264; AID694270
Coagulation factor XIIHomo sapiens (human)Ki0.08150.00251.86697.2500AID1798260
PapainCarica papaya (papaya)IC50 (µMol)91.00000.00201.504510.0000AID155386
CholinesteraseHomo sapiens (human)Ki20.08690.00001.51739.7300AID1798260; AID1798261; AID302993
Receptor-type tyrosine-protein phosphatase CHomo sapiens (human)IC50 (µMol)1.36670.30002.757110.0000AID1799795; AID42805; AID42929
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)30.00000.00053.49849.7600AID157215
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)1.92000.00002.37899.7700AID1888748
AcetylcholinesteraseHomo sapiens (human)Ki100.00000.00001.27869.7300AID1798261; AID302992
Liver carboxylesterase 1Homo sapiens (human)Ki0.04990.00252.01368.4800AID1798260; AID302991; AID731515
Adenosine receptor A1Bos taurus (cattle)IC50 (µMol)0.70000.00001.09106.7400AID42805
Genome polyprotein Human rhinovirus sp.IC50 (µMol)1.40000.00052.98388.2000AID163631
putative polyproteinIC50 (µMol)3.07400.25083.82838.4620AID720577; AID720578
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
serine/threonine-protein kinase PLK1Homo sapiens (human)EC50 (µMol)50.00001.58301.58301.5830AID876; AID936
recombinase AMycobacterium tuberculosis H37RvEC50 (µMol)7.19350.018023.2882287.6000AID434968; AID435010
streptokinase A precursorStreptococcus pyogenes M1 GASEC50 (µMol)1.25500.06008.9128130.5170AID1902
Protein S100-A4Homo sapiens (human)EC50 (µMol)3.80003.80005.70007.6000AID1618872
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
replicative DNA helicaseMycobacterium tuberculosis H37RvAC5011.63700.057030.7482325.3000AID449749; AID449750
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (212)

Processvia Protein(s)Taxonomy
prostaglandin metabolic processCocaine esteraseHomo sapiens (human)
xenobiotic metabolic processCocaine esteraseHomo sapiens (human)
catabolic processCocaine esteraseHomo sapiens (human)
telomere maintenanceTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
telomere maintenance via telomeraseTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrion organizationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of gene expressionTelomerase reverse transcriptaseHomo sapiens (human)
DNA strand elongationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of Wnt signaling pathwayTelomerase reverse transcriptaseHomo sapiens (human)
siRNA processingTelomerase reverse transcriptaseHomo sapiens (human)
regulation of protein stabilityTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of hair cycleTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of neuron apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of angiogenesisTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of glucose importTelomerase reverse transcriptaseHomo sapiens (human)
response to cadmium ionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityTelomerase reverse transcriptaseHomo sapiens (human)
establishment of protein localization to telomereTelomerase reverse transcriptaseHomo sapiens (human)
cellular response to hypoxiaTelomerase reverse transcriptaseHomo sapiens (human)
DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
replicative senescenceTelomerase reverse transcriptaseHomo sapiens (human)
siRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of miRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of transdifferentiationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein localization to nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell migrationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of endothelial cell apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of stem cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of cellular senescenceTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandTelomerase reverse transcriptaseHomo sapiens (human)
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma kallikrein-kinin cascadeCoagulation factor XIIHomo sapiens (human)
Factor XII activationCoagulation factor XIIHomo sapiens (human)
blood coagulation, intrinsic pathwayCoagulation factor XIIHomo sapiens (human)
positive regulation of plasminogen activationCoagulation factor XIIHomo sapiens (human)
protein processingCoagulation factor XIIHomo sapiens (human)
protein autoprocessingCoagulation factor XIIHomo sapiens (human)
positive regulation of blood coagulationCoagulation factor XIIHomo sapiens (human)
zymogen activationCoagulation factor XIIHomo sapiens (human)
fibrinolysisCoagulation factor XIIHomo sapiens (human)
innate immune responseCoagulation factor XIIHomo sapiens (human)
response to misfolded proteinCoagulation factor XIIHomo sapiens (human)
positive regulation of fibrinolysisCoagulation factor XIIHomo sapiens (human)
blood coagulationCoagulation factor XIIHomo sapiens (human)
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
MAPK cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
natural killer cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of T cell mediated cytotoxicityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of cytokine-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
hematopoietic progenitor cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of immunoglobulin productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of humoral immune response mediated by circulating immunoglobulinReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of protein kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of cell adhesion involved in substrate-bound cell migrationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
leukocyte cell-cell adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell surface receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
response to gamma radiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of gene expressionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
dephosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of B cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of protein autophosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of interleukin-8 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of interleukin-2 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of interleukin-2 productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of tumor necrosis factor productionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heterotypic cell-cell adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell activationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
gamma-delta T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of MAPK cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell cycle phase transitionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive thymic T cell selectionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative thymic T cell selectionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of gamma-delta T cell differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of protein kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of receptor signaling pathway via JAK-STATReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
alpha-beta T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of alpha-beta T cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of isotype switching to IgG isotypesReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
bone marrow developmentReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
stem cell developmentReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of phagocytosisReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of phagocytosisReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of calcium-mediated signalingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
T cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
B cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of T cell receptor signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of antigen receptor-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
release of sequestered calcium ion into cytosolReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
defense response to virusReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of cell cycleReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of Fc receptor mediated stimulatory signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
regulation of protein tyrosine kinase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
extrinsic apoptotic signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
negative regulation of microglial cell activationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
response to aldosteroneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
DN2 thymocyte differentiationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of hematopoietic stem cell migrationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of stem cell proliferationReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
cholesterol biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
response to toxic substanceLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol effluxLiver carboxylesterase 1Homo sapiens (human)
negative regulation of cholesterol storageLiver carboxylesterase 1Homo sapiens (human)
epithelial cell differentiationLiver carboxylesterase 1Homo sapiens (human)
cholesterol homeostasisLiver carboxylesterase 1Homo sapiens (human)
reverse cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
medium-chain fatty acid metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cellular response to cholesterolLiver carboxylesterase 1Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulusLiver carboxylesterase 1Homo sapiens (human)
cholesterol ester hydrolysis involved in cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid secretionLiver carboxylesterase 1Homo sapiens (human)
lipid catabolic processLiver carboxylesterase 1Homo sapiens (human)
epithelial to mesenchymal transitionProtein S100-A4Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein S100-A4Homo sapiens (human)
positive chemotaxisProtein S100-A4Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A1Bos taurus (cattle)
response to purine-containing compoundAdenosine receptor A1Bos taurus (cattle)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (66)

Processvia Protein(s)Taxonomy
methylumbelliferyl-acetate deacetylase activityCocaine esteraseHomo sapiens (human)
carboxylesterase activityCocaine esteraseHomo sapiens (human)
carboxylic ester hydrolase activityCocaine esteraseHomo sapiens (human)
tRNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
transcription coactivator bindingTelomerase reverse transcriptaseHomo sapiens (human)
DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase activityTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA reverse transcriptase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed DNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA-dependent RNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
identical protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein homodimerization activityTelomerase reverse transcriptaseHomo sapiens (human)
metal ion bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein-folding chaperone bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
template-free RNA nucleotidyltransferaseTelomerase reverse transcriptaseHomo sapiens (human)
telomeric DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
serine-type endopeptidase activityCoagulation factor XIIHomo sapiens (human)
calcium ion bindingCoagulation factor XIIHomo sapiens (human)
protein bindingCoagulation factor XIIHomo sapiens (human)
misfolded protein bindingCoagulation factor XIIHomo sapiens (human)
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
signaling receptor bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heparin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
protein kinase bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
ankyrin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
spectrin bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
heparan sulfate proteoglycan bindingReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
sterol esterase activityLiver carboxylesterase 1Homo sapiens (human)
methylumbelliferyl-acetate deacetylase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylesterase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylic ester hydrolase activityLiver carboxylesterase 1Homo sapiens (human)
RNA bindingProtein S100-A4Homo sapiens (human)
actin bindingProtein S100-A4Homo sapiens (human)
protein bindingProtein S100-A4Homo sapiens (human)
chemoattractant activityProtein S100-A4Homo sapiens (human)
identical protein bindingProtein S100-A4Homo sapiens (human)
transition metal ion bindingProtein S100-A4Homo sapiens (human)
RAGE receptor bindingProtein S100-A4Homo sapiens (human)
calcium-dependent protein bindingProtein S100-A4Homo sapiens (human)
calcium ion bindingProtein S100-A4Homo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (57)

Processvia Protein(s)Taxonomy
endoplasmic reticulumCocaine esteraseHomo sapiens (human)
endoplasmic reticulum lumenCocaine esteraseHomo sapiens (human)
intracellular membrane-bounded organelleCocaine esteraseHomo sapiens (human)
PML bodyTelomerase reverse transcriptaseHomo sapiens (human)
chromosome, telomeric regionTelomerase reverse transcriptaseHomo sapiens (human)
nucleusTelomerase reverse transcriptaseHomo sapiens (human)
nucleoplasmTelomerase reverse transcriptaseHomo sapiens (human)
telomerase holoenzyme complexTelomerase reverse transcriptaseHomo sapiens (human)
nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
cytosolTelomerase reverse transcriptaseHomo sapiens (human)
plasma membraneTelomerase reverse transcriptaseHomo sapiens (human)
nuclear speckTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrial nucleoidTelomerase reverse transcriptaseHomo sapiens (human)
TERT-RMRP complexTelomerase reverse transcriptaseHomo sapiens (human)
telomerase catalytic core complexTelomerase reverse transcriptaseHomo sapiens (human)
nuclear telomere cap complexTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed RNA polymerase complexTelomerase reverse transcriptaseHomo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular regionCoagulation factor XIIHomo sapiens (human)
extracellular spaceCoagulation factor XIIHomo sapiens (human)
plasma membraneCoagulation factor XIIHomo sapiens (human)
collagen-containing extracellular matrixCoagulation factor XIIHomo sapiens (human)
extracellular exosomeCoagulation factor XIIHomo sapiens (human)
extracellular spaceCoagulation factor XIIHomo sapiens (human)
rough endoplasmic reticulumCoagulation factor XIIHomo sapiens (human)
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
focal adhesionReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
external side of plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cytoplasmic side of plasma membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
cell surfaceReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
secretory granule membraneReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
blebReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membrane raftReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
synapseReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
membrane microdomainReceptor-type tyrosine-protein phosphatase CHomo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
cytoplasmLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulum lumenLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
cytosolLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
extracellular spaceProtein S100-A4Homo sapiens (human)
extracellular regionProtein S100-A4Homo sapiens (human)
extracellular spaceProtein S100-A4Homo sapiens (human)
nucleusProtein S100-A4Homo sapiens (human)
nucleoplasmProtein S100-A4Homo sapiens (human)
cytosolProtein S100-A4Homo sapiens (human)
perinuclear region of cytoplasmProtein S100-A4Homo sapiens (human)
collagen-containing extracellular matrixProtein S100-A4Homo sapiens (human)
extracellular exosomeProtein S100-A4Homo sapiens (human)
perinuclear region of cytoplasmProtein S100-A4Homo sapiens (human)
nucleusProtein S100-A4Homo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (71)

Assay IDTitleYearJournalArticle
AID504787Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear rec2006Assay and drug development technologies, Jun, Volume: 4, Issue:3
Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID731515Inhibition of human CE1 using o-NPA as substrate by spectrophotometric assay2013Journal of natural products, Jan-25, Volume: 76, Issue:1
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
AID1892521Drug uptake in LPS-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with LPS and L-NAA for 16 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID210280Cytotoxicity measured against human T-cells2001Journal of medicinal chemistry, May-24, Volume: 44, Issue:11
Potent reversible inhibitors of the protein tyrosine phosphatase CD45.
AID762062Cytotoxicity against human HCT116 cells after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID155386Inhibitory activity against papain using HPLC assay2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.
AID1892522Drug uptake in INFgamma-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with INFgamma and L-NAA for 16 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID1888752Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells using kynuramine as substrate at 100 uM after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID302991Inhibition of human carboxylesterase 12007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1892527Cytotoxicity against mouse HT-22 cells cocultured with BV-2 cells assessed as increase in live/dead cells ratio at 5 uM after 48 hrs by Live/dead staining based fluorescence microscopic analysis2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID42929Inhibitory concentration against CD45 protein-tyrosine phosphatase using lck-10mer as substrate2001Journal of medicinal chemistry, May-24, Volume: 44, Issue:11
Potent reversible inhibitors of the protein tyrosine phosphatase CD45.
AID694271Inhibition of human recombinant telomerase activity in rabbit reticulocytes at 50 uM after 5 mins preincubation in presence of 5 mM of DTT2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID157215Inhibitory concentration against PTP1B using lck as substrate2001Journal of medicinal chemistry, May-24, Volume: 44, Issue:11
Potent reversible inhibitors of the protein tyrosine phosphatase CD45.
AID1892524Drug uptake in mouse HT-22 cells cocultured with BV-2 cells assessed as increase in fluorescence at 10 uM after 12 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID762060Induction of apoptosis in human HL60 cells assessed as caspase-3 activation at 10 uM after 4 hrs by FACS flow cytometric analysis2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID694275Irreversible inhibition of human recombinant telomerase activity in rabbit reticulocytes assessed preincubated for 1 hr with 50 uM compound and 5 mM of DTT followed by 3.5 U of catalase addition2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID762061Cytotoxicity against human HL60 cells after 24 hrs by WST-1 assay2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID210283In vitro inhibition of human T-cell proliferation2001Journal of medicinal chemistry, May-24, Volume: 44, Issue:11
Potent reversible inhibitors of the protein tyrosine phosphatase CD45.
AID163631Inhibitory activity against HRV 3Cpro using HPLC assay2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.
AID1892519Drug uptake in INFgamma-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with INFgamma for 12 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID1892502Drug uptake in L-arginine stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with L-arginine and carboxyl-PTIO for 3 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID1888748Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID1892500Cytotoxicity against mouse HT-22 cells cocultured with BV-2 cells assessed as cell viability at 5 uM after 48 hrs by CCK8 assay (Rvb = 5.19 +/- 1.60%)2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID302993Inhibition of human butyrylcholinesterase2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302990Inhibition of human intestinal carboxylesterase2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID302992Inhibition of human acetylcholinesterase 12007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1892526Drug uptake in INFgamma-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with INFgamma and carboxyl-PTIO for 3 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID42805In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrate2001Journal of medicinal chemistry, May-24, Volume: 44, Issue:11
Potent reversible inhibitors of the protein tyrosine phosphatase CD45.
AID694274Inhibition of human recombinant telomerase activity in rabbit reticulocytes at 50 uM for 1 hr in presence of 5 mM of DTT and 3.5 U of catalase2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID762059Induction of apoptosis in human HL60 cells assessed as DNA fragmentation at 10 uM after 6 hrs by electrophoretic analysis2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID1892517Drug uptake in mouse BV-2 cells assessed as increase in fluorescence at 10 uM after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID1892523Drug uptake in L-arginine stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with L-arginine and L-NAA for 16 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID694280Inhibition of human recombinant telomerase activity in rabbit reticulocytes pre-incubated before pre-assembly measured after 90 mins post dose by gel electrophoresis method based direct primer extension assay relative to untreated control2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID731514Inhibition of human iCE using o-NPA as substrate by spectrophotometric assay2013Journal of natural products, Jan-25, Volume: 76, Issue:1
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
AID1892525Drug uptake in LPS-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with LPS and carboxyl-PTIO for 3 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID694264Inhibition of human recombinant telomerase activity in rabbit reticulocytes after 90 mins by telomerase assemblage gel electrophoresis2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID694272Inhibition of human recombinant telomerase activity in rabbit reticulocytes at 50 uM after 60 mins in presence of 5 mM of DTT2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID694270Inhibition of pre-assembled human recombinant telomerase activity in rabbit reticulocytes after 90 mins by gel electrophoresis method based direct primer extension assay2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID1892520Drug uptake in L-arginine stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with L-arginine for 12 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID762064Cytotoxicity against human HCT116 cells at >2.5 uM after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID694273Inhibition of human recombinant telomerase activity in rabbit reticulocytes after 5 to 60 mins in presence of 5mM of DTT2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID224910Percent inhibition against papain2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.
AID694279Inhibition of pre-assembled human recombinant telomerase activity in rabbit reticulocytes after 90 mins by gel electrophoresis method based direct primer extension assay relative to untreated control2011Bioorganic & medicinal chemistry letters, Dec-15, Volume: 21, Issue:24
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
AID762063Cytotoxicity against human HL60 cells at 5 uM after 24 hrs by WST-1 assay2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
AID1892518Drug uptake in LPS-stimulated mouse BV-2 cells assessed as increase in fluorescence at 10 uM pretreated with LPS for 12 hrs followed by compound addition and measured after 3 hrs2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Rational Design of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model of Alzheimer's Disease.
AID1799795Phosphatase Activity Assay from Article 10.1074/jbc.M809633200: \\Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis.\\2009The Journal of biological chemistry, May-08, Volume: 284, Issue:19
Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis.
AID1798260Enzyme Inhibition Assay from Article 10.1021/jm0706867: \\Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.\\2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1798261Cholinesterase Inhibition Assay from Article 10.1021/jm0706867: \\Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.\\2007Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (134)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (5.97)18.7374
1990's21 (15.67)18.2507
2000's39 (29.10)29.6817
2010's53 (39.55)24.3611
2020's13 (9.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.24 (24.57)
Research Supply Index4.92 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index55.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.47%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other134 (98.53%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]